Genotype-Guided P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention: A Bayesian Analysis.
Vibhu ParchaBrittain F HeindlTanja DudenbostelRajat KalraNita A LimdiNaveen L PereiraGarima AroraPankaj AroraPublished in: Circulation. Genomic and precision medicine (2021)
Bayesian analysis of the TAILOR-PCI trial provides clinically meaningful data on the posterior probability of reducing MACE using genotype-guided P2Y12 inhibitor therapy after PCI.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- acute myocardial infarction
- st segment elevation myocardial infarction
- coronary artery disease
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery bypass grafting
- atrial fibrillation
- clinical trial
- heart failure
- study protocol
- electronic health record
- phase iii
- phase ii
- mesenchymal stem cells
- coronary artery bypass
- artificial intelligence
- left ventricular
- deep learning
- data analysis
- smoking cessation